Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heart

Journal article

AMP-activated protein kinase (AMPK), the key sensor and regulator of cellular energy status, is a heterotrimeric enzyme with multiple isoforms for each subunit (α1/α 2; β1/β2; γ1/γ2/γ3). Mutations in PRKAG2, which encodes the γ2 regulatory subunit, cause a cardiomyopathy characterized by hypertrophy and conduction abnormalities. The two reported PRKAG2 transcript variants, γ2-short and γ2-long (encoding 328 and 569 amino acids respectively), are both widely expressed in adult tissues. We show that both γ2 variants are also expressed during cardiogenesis in mouse embryos; expression of the γ3 isoform was also detected unexpectedly at this stage. As neither γ2 transcript is cardiac specific nor differentially expressed during embryogenesis, it is paradoxical that the disease is largely restricted to the heart. However, a recently annotated γ2 transcript, termed γ2-3B as transcription starts at an alternative exon 3b, has been identified; it is spliced in-frame to exon 4 thus generating a protein of 443 residues in mouse with the first 32 residues being unique. It is increasingly expressed in the developing mouse heart and quantitative PCR analysis established that γ2-3B is the major PRKAG2 transcript (~. 60%) in human heart. Antibody against the novel N-terminal sequence showed that γ2-3B is predominantly expressed in the heart where it is the most abundant γ2 protein. The abundance of γ2-3B and its tissue specificity indicate that γ2-3B may have non-redundant role in the heart and hence mediate the predominantly cardiac phenotype caused by PRKAG2 mutations. © 2012 Elsevier Ltd.

Authors: Pinter, K; Grignani, RT; Czibik, G; Farza, H; Watkins, H

• Journal: Journal of Molecular and Cellular Cardiology
• Volume: 53
• Issue: 3
• Pages: 342-349
• Publication date: 2012-09-01
• DOI: 10.1016/j.yjmcc.2012.05.017
• EISSN: 1095-8584
• ISSN: 0022-2828
• Language: English
• Keywords: PRKAG2 transcripts; AMP-activated protein kinase; Cardiomyopathy